figshare
Browse

CRISPRtargetID

Published on by Francesco Iorio
Supplementary Results related to the publication "Prioritisation of cancer therapeutic targets using CRISPR-Cas9 screens" Nature 2019 [in press], DOI: 10.1038/s41586-019-1103-9 Details in the ReadMe file

Cite items from this project

DataCite
3 Biotech
3D Printing in Medicine
3D Research
3D-Printed Materials and Systems
4OR
AAPG Bulletin
AAPS Open
AAPS PharmSciTech
Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg
ABI Technik (German)
Academic Medicine
Academic Pediatrics
Academic Psychiatry
Academic Questions
Academy of Management Discoveries
Academy of Management Journal
Academy of Management Learning and Education
Academy of Management Perspectives
Academy of Management Proceedings
Academy of Management Review

cite all items

Funding

The work was funded by Open Targets (OTAR015) to M.G., K.Y. and J.S-R. M.G lab is supported CRUK (C44943/A22536), SU2C (SU2C-AACR-DT1213) and Wellcome Trust (102696). Also supported by AIRC, Associazione Italiana per la Ricerca sul Cancro, Investigator Grants 20697 (A.B.) and 18532 (L.T.) and 5x1000 grant 21091 (A.B. and L.T.); European Research Council Consolidator Grant 724748 – BEAT (A.B.); Fondazione Piemontese per la Ricerca sul Cancro-ONLUS, 5x1000 Ministero della Salute 2011 and 2014 (L.T.); and Transcan, TACTIC (L.T.).

Share

email